Contrast Media Injectors Market Trends, Industry & Size 2031
Contrast Media Injectors Market Trends, Industry & Size 2031
Segments - Global Contrast Media Injectors Market by Products {Injector Systems (CT Injectors, MRI Injectors, and DSA Injectors), Consumables (Syringes, Tubes, and Others), Accessories}, Injector Types (Dual-Head Injectors, Single-Head Injectors, and Syringeless Injectors), Applications (Radiology, Interventional Radiology, and Interventional Cardiology), End-Users (Hospitals, Diagnostic Centers, and Ambulatory Surgery Centers), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 – 2027
Upcoming
| Report ID :HC-2598
| 4.5 Rating
| 81 Reviews
| 375 Pages
| Format :
Report Description
Contrast Media Injectors Market Outlook
The global contrast media injectors market was valued at USD 1,027.9 Million in 2019 and is projected to reach USD 1,589.7 Million by 2027, expanding at a CAGR of 6.8% during the forecast period. Demand for contrast media injectors is driven by the increasing demand for non-invasive and minimally invasive surgeries, growing incidence of several chronic diseases, rising research and development activities in the healthcare sector, and rising approvals for contrast agents.
Contrast media injectors are used to inject contrast media to improve the perfusion in tissues and blood. Contrast media injectors are used to inject contrast media at the time of diagnostic imaging to enhance image quality and improve patient safety.
Thus, the increase in the number of cancer and CVD cases will stimulate the demand for improved healthcare facilities and advanced diagnostic imaging procedures, which, in turn, will drive the market for contrast media injectors.
Contrast Media Injectors Market Dynamics
Non-invasive and minimally invasive surgical procedures provide several advantages, such as tiny incisions instead of a large opening, quick recovery, less hospital stays, less pain, and minor surgical wounds. The use of contrast media injectors in these procedures offers high-quality real-time imaging of the surgical site and ensures the treatment of appropriate area by surgeons.
Thus, the adoption of contrast media injectors for minimally invasive surgeries is increasing, which is further fueling the market.
Cases of chronic diseases requiring accurate diagnosis through different imaging systems such as computed tomography (CT) scanners and magnetic resonance imaging (MRI) equipment that requires contrast media injectors. Growing adoption of poor lifestyle is increasing incidences of chronic diseases, which is projected to drive the contrast media injectors market during the forecast period.
The contrast media injector market is expected to grow, due to the increasing expenditure on healthcare sector, and adoption of advanced diagnostics. Research and development areas of contrast media involves development of contrast media, and optimization of imaging technology for maximizing image contrast media. Moreover, the presence of various key vendors and their research and development (R&D) investments boost the growth of the market.
Rising demand for contrast agents has significantly increased over the past years, and introduction of Clariscan increases clinical offering for the US radiologists, that enhances visualization for providing better patient care. For instance, the U.S.
Food and Drug Administration (FDA) has approved Clariscan is a macrocyclic, gadolinium-based, ionic, magnetic resonance imaging (MRI) contrast agent. It has been approved in more than 55 countries across the world and more than 4 Million patient doses shipped in different countries. Hence, rising number of contrast agent approvals are propelling the market.
Rivalry amongst competitors has led to high pressure on pricing strategies. Moreover, the high costs of system and side-effects of contrast agents including iodinated contrast, gadolinium, barium, and microbubble agents, is expected to limit their adoption by healthcare professionals.
The cost of contrast media injectors differs, based on the types of injectors such as dual-head, single-head, and syringeless injectors. Also, cost of consumables is high as tube and syringe cannot be used again, due to hygiene and safety issues. This is a major burden for end users, thus the aforementioned factors are hampering the growth of contrast media injectors market.
Use of medical imaging as well as contrast media is expected to increase worldwide, due to rising use of computed tomography (CT), magnetic resonance imaging (MRI) and angiography procedures, and disease burdens. Rising awareness of early diagnosis of disease is expected to further drive the contrast media injectors market.
Increasing awareness about patient disease diagnosis helps the population to support imaging diagnostic systems. Hence, lucrative growth opportunities in the CT scanners and MRI equipment are expected to boost the market.
Contrast Media Injectors Market Segmental Outlook
In terms of products, the contrast media injectors market is divided into injector systems, consumables, and accessories. The injector system is further divided into CT injectors, MRI injectors, and DSA injectors.
The consumables segment is further segmented into syringes, tubes, and others. The consumables segment is expected to hold a significant share of the market and is projected to expand at a substantial CAGR during the forecast period, owing to rising requirement of consumables in order to maintain hygienic and safety conditions during diagnostic procedures.
The CT injector sub-segment is expected to expand at a considerable CAGR, owing to the widespread application of CT injectors in cancer surgery, cardiovascular surgery, neurosurgery, and spinal procedures. Moreover, growing adoption of minimally invasive surgeries is projected to boost the demand for CT injectors during the forecast period.
Based on injector types, the contrast media injectors market is categorized as dual-head injectors, single-head injectors, and syringeless injectors. The syringeless injectors segment is expected to expand at a significant pace during the forecast period, due to its advantages such as high efficiency, user-friendliness, and minimum wastage of contrast media.
Moreover, leading market players of contrast media injectors are concentrating on the development of syringeless injectors, which in turn, is anticipated to drive the segment. The single-head injectors segment is expected to hold a significant share of the market and is projected to expand at a substantial CAGR during the forecast period, as it is widely used for CT, angiography, and MRI.
In terms of applications, the contrast media injectors market is segmented into radiology, interventional radiology, and interventional cardiology. The radiology segment is expected to expand at a significant pace during the forecast period, due to increasing number of radiology techniques using contrast media injectors.
The growth of the segment is attributed to the diagnosis of several diseases, including breast cancer, heart conditions, broken bones, colon cancer, gastrointestinal conditions, and blood clots. The interventional cardiology segment is expected to grow at a significant pace, owing to increasing prevalence of cardiac diseases, including heart valve problems, arrhythmia, heart attacks, and strokes
In terms of end-users, the contrast media injectors market is categorized as hospitals, diagnostic centers, and Ambulatory Surgery Centers (ASCs). The hospital segment is projected to expand at a considerable pace during the forecast period, due to rising admissions of patients suffering from cardiovascular diseases, cancer, and neurological disorders.
The diagnostic centers segment is expected to grow at a significant CAGR, owing to surging number of private imaging centers (driven by the increasing demand for diagnostic imaging and early diagnosis) and the absence of imaging modalities in mid-scale and small hospitals.
Growing focus on the expansion of healthcare infrastructure in developing countries in Africa and Asia Pacific is anticipated to propel the hospital segment.
Contrast Media Injectors Market Regional Outlook
On the basis of regions, the global contrast media injectors market is fragmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is expected to dominate the market during the forecast period, due to factors such as growing incidence of minimally invasive procedures and rising prevalence of chronic diseases owing to changing lifestyles.
The US holds significant share in the market during the forecast period, due to technological advancements in contrast media injectors devices and increasing expenditure by key players along with rising regulatory approvals.
Europe region hold substantial share in the market during the forecast period, due to the local presence of various leading companies, such as Bracco Group, and others. The market in China is expected to expand at a rapid CAGR during the forecast period, due to rising disposable income and increase in funding for research and development (R&D).
Key Benefits for Industry Participants & Stakeholders
- In-depth analysis of the global contrast media injectors market
- Historical, current, and projected market size in terms of value (USD million) and volume (tons)
- Potential & niche segments and regions exhibiting promising growth covered
- Industry drivers, restraints, and opportunities covered in the study
- Recent industry trends and developments
- Competitive landscape & strategies of key players
Segments
By Products
- Injector Systems
- CT Injectors
- MRI Injectors
- DSA Injectors
- Consumables
- Syringes
- Tubes
- Others
- Accessories
By Injector Types
- Dual-head Injectors
- Single-head Injectors
- Syringeless Injectors
By Applications
- Radiology
- Interventional Radiology
- Interventional Cardiology
By End-Users
- Hospitals
- Diagnostic Centers
- Ambulatory Surgery Centers (ASCs)
By Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Players
- ulrich GmbH & Co. KG
- GENERAL ELECTRIC COMPANY
- Bayer HealthCare LLC
- Bracco Imaging S.p.A.
- Guerbet
- SINO MDT
- APOLLO RT Co. Ltd.
- Shenzhen Anke High-tech Co., Ltd.
- Shenzhen Seacrown Electromechanical Co., Ltd
- Nemoto Kyorindo Co., Ltd.
- Smiths Group plc
- AngioDynamics
- MEDTRON AG
Competitive Landscape
- Prominent manufacturers operational in the global contrast media injectors market include Bracco, Bayer AG, Guerbet, Shenzhen Anke High-tech Co., Ltd., Nemoto Kyorindo co., Ltd., Sino Medical-Device Technology Co., Ltd., and Imaxeon.
- These companies are considered as key manufacturers of contrast media injectors based on their revenue, research & development (R&D) activities, regional presence, and supply chain management system.
Video Summary for Contrast Media Injectors Market
Frequently Asked Questions
Major Manufactures are ulrich GmbH & Co. KG, GENERAL ELECTRIC COMPANY, Bayer HealthCare LLC, Bracco Imaging S.p.A., Guerbet, SINO MDT, APOLLO RT Co. Ltd.
The base year considered for the global contrast media injectors market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.
The market is expected to decrease around 2.3% in 2020, owing to the negative impact of COVID-19 pandemic on the contrast media injectors market.
Factors such as competitive strength and market positioning are key areas, which are considered while selecting top companies to be profiled.
Demand for contrast media injectors is expected to continue to increase over the forecast period, taking into account increasing demand for non-invasive and minimally invasive surgeries, increasing occurrence of several chronic diseases, rising research and development activities in the healthcare sector, and rising approvals for contrast agents.
Applications in the global contrast media injectors market includes radiology, interventional radiology, and interventional cardiology.
In addition to market size (in USD Million) and market volume (in Thousand Units), company market share (in % for base year 2019), other data such as Pricing Analysis & Forecast, By Product, Region, and Country; Regulatory Requirements, Reimbursement Scenario, Technological Trends & Advancements Overview, Business Model of Key Companies, Installed Base By Country: CT, MRI, DSA Scanning Machines, macro-economic factors and COVID-19 impact on the value chain are available in the final report.
According to the Growth Market Reports, the market for contrast media injectors is likely to register a CAGR of 6.8% during forecast period 2020-2027, with an anticipated valuation of USD 1,589.7 million by the end of 2027.
Yes, the report provides supply chain analysis along with a list of raw material suppliers, manufacturers, distributors, and customers.
Additional company profiles are provided on request.
Table Of Content
Chapter 1 Executive SummaryChapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contrast Media Injectors Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Contrast Media Injectors Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Contrast Media Injectors Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Contrast Media Injectors Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Contrast Media Injectors Market Size & Volume & Forecast, 2017-2027
4.5.1 Contrast Media Injectors Market Size & Volume and Y-o-Y Growth
4.5.2 Contrast Media Injectors Market Absolute $ Opportunity
4.6 Pricing Analysis & Forecast, By Product, Region, and Country, 2017-2027
4.7 Regulatory Requirements
4.8 Reimbursement Scenario
4.9 Technological Trends & Advancements Overview
4.10 Business Model of Key Companies
4.11 Installed Base By Country: CT, MRI, DSA Scanning Machines
Chapter 5 Global Contrast Media Injectors Market Analysis and Forecast By Products
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Products
5.1.2 Basis Point Share (BPS) Analysis By Products
5.1.3 Absolute $ Opportunity Assessment By Products
5.2 Contrast Media Injectors Market Size & Volume Forecast By Products
5.2.1 Injector Systems
5.2.1.1 CT Injectors
5.2.1.2 MRI Injectors
5.2.1.3 DSA Injectors
5.2.2 Consumables
5.2.2.1 Syringes
5.2.2.2 Tubes
5.2.2.3 Others
5.2.3 Accessories
5.3 Market Attractiveness Analysis By Products
Chapter 6 Global Contrast Media Injectors Market Analysis and Forecast By Injector Types
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By Injector Types
6.1.2 Basis Point Share (BPS) Analysis By Injector Types
6.1.3 Absolute $ Opportunity Assessment By Injector Types
6.2 Contrast Media Injectors Market Size & Volume Forecast By Injector Types
6.2.1 Single-head Injectors
6.2.2 Dual-head Injectors
6.2.3 Syringeless Injectors
6.3 Market Attractiveness Analysis By Injector Types
Chapter 7 Global Contrast Media Injectors Market Analysis and Forecast By Applications
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities By Applications
7.1.2 Basis Point Share (BPS) Analysis By Applications
7.1.3 Absolute $ Opportunity Assessment By Applications
7.2 Contrast Media Injectors Market Size & Volume Forecast By Applications
7.2.1 Radiology
7.2.2 Interventional Radiology
7.2.3 Interventional Cardiology
7.3 Market Attractiveness Analysis By Applications
Chapter 8 Global Contrast Media Injectors Market Analysis and Forecast By End-Users
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities By End-Users
8.1.2 Basis Point Share (BPS) Analysis By End-Users
8.1.3 Absolute $ Opportunity Assessment By End-Users
8.2 Contrast Media Injectors Market Size & Volume Forecast By End-Users
8.2.1 Hospitals
8.2.2 Diagnostic Centers
8.2.3 Ambulatory Surgery Centers (ASCs)
8.3 Market Attractiveness Analysis By End-Users
Chapter 9 Global Contrast Media Injectors Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Contrast Media Injectors Market Size & Volume Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Contrast Media Injectors Analysis and Forecast
11.1 Introduction
11.2 North America Contrast Media Injectors Market Size & Volume Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Contrast Media Injectors Market Size & Volume Forecast By Products
11.6.1 Injector Systems
11.6.1.1 CT Injectors
11.6.1.2 MRI Injectors
11.6.1.3 DSA Injectors
11.6.2 Consumables
11.6.2.1 Syringes
11.6.2.2 Tubes
11.6.2.3 Others
11.6.3 Accessories
11.7 Basis Point Share (BPS) Analysis By Products
11.8 Absolute $ Opportunity Assessment By Products
11.9 Market Attractiveness Analysis By Products
11.10 North America Contrast Media Injectors Market Size & Volume Forecast By Injector Types
11.10.1 Single-head Injectors
11.10.2 Dual-head Injectors
11.10.3 Syringeless Injectors
11.11 Basis Point Share (BPS) Analysis By Injector Types
11.12 Absolute $ Opportunity Assessment By Injector Types
11.13 Market Attractiveness Analysis By Injector Types
11.14 North America Contrast Media Injectors Market Size & Volume Forecast By Applications
11.14.1 Radiology
11.14.2 Interventional Radiology
11.14.3 Interventional Cardiology
11.15 Basis Point Share (BPS) Analysis By Applications
11.16 Absolute $ Opportunity Assessment By Applications
11.17 Market Attractiveness Analysis By Applications
11.18 North America Contrast Media Injectors Market Size & Volume Forecast By End-Users
11.18.1 Hospitals
11.18.2 Diagnostic Centers
11.18.3 Ambulatory Surgery Centers (ASCs)
11.19 Basis Point Share (BPS) Analysis By End-Users
11.20 Absolute $ Opportunity Assessment By End-Users
11.21 Market Attractiveness Analysis By End-Users
Chapter 12 Europe Contrast Media Injectors Analysis and Forecast
12.1 Introduction
12.2 Europe Contrast Media Injectors Market Size & Volume Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Contrast Media Injectors Market Size & Volume Forecast By Products
12.6.1 Injector Systems
12.6.1.1 CT Injectors
12.6.1.2 MRI Injectors
12.6.1.3 DSA Injectors
12.6.2 Consumables
12.6.2.1 Syringes
12.6.2.2 Tubes
12.6.2.3 Others
12.6.3 Accessories
12.7 Basis Point Share (BPS) Analysis By Products
12.8 Absolute $ Opportunity Assessment By Products
12.9 Market Attractiveness Analysis By Products
12.10 Europe Contrast Media Injectors Market Size & Volume Forecast By Injector Types
12.10.1 Single-head Injectors
12.10.2 Dual-head Injectors
12.10.3 Syringeless Injectors
12.11 Basis Point Share (BPS) Analysis By Injector Types
12.12 Absolute $ Opportunity Assessment By Injector Types
12.13 Market Attractiveness Analysis By Injector Types
12.14 Europe Contrast Media Injectors Market Size & Volume Forecast By Applications
12.14.1 Radiology
12.14.2 Interventional Radiology
12.14.3 Interventional Cardiology
12.15 Basis Point Share (BPS) Analysis By Applications
12.16 Absolute $ Opportunity Assessment By Applications
12.17 Market Attractiveness Analysis By Applications
12.18 Europe Contrast Media Injectors Market Size & Volume Forecast By End-Users
12.18.1 Hospitals
12.18.2 Diagnostic Centers
12.18.3 Ambulatory Surgery Centers (ASCs)
12.19 Basis Point Share (BPS) Analysis By End-Users
12.20 Absolute $ Opportunity Assessment By End-Users
12.21 Market Attractiveness Analysis By End-Users
Chapter 13 Asia Pacific Contrast Media Injectors Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.2.8 Indonesia
13.2.9 Vietnam
13.2.10 Pakistan
13.2.11 Philippines
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By Products
13.6.1 Injector Systems
13.6.1.1 CT Injectors
13.6.1.2 MRI Injectors
13.6.1.3 DSA Injectors
13.6.2 Consumables
13.6.2.1 Syringes
13.6.2.2 Tubes
13.6.2.3 Others
13.6.3 Accessories
13.7 Basis Point Share (BPS) Analysis By Products
13.8 Absolute $ Opportunity Assessment By Products
13.9 Market Attractiveness Analysis By Products
13.10 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By Injector Types
13.10.1 Single-head Injectors
13.10.2 Dual-head Injectors
13.10.3 Syringeless Injectors
13.11 Basis Point Share (BPS) Analysis By Injector Types
13.12 Absolute $ Opportunity Assessment By Injector Types
13.13 Market Attractiveness Analysis By Injector Types
13.14 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By Applications
13.14.1 Radiology
13.14.2 Interventional Radiology
13.14.3 Interventional Cardiology
13.15 Basis Point Share (BPS) Analysis By Applications
13.16 Absolute $ Opportunity Assessment By Applications
13.17 Market Attractiveness Analysis By Applications
13.18 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By End-Users
13.18.1 Hospitals
13.18.2 Diagnostic Centers
13.18.3 Ambulatory Surgery Centers (ASCs)
13.19 Basis Point Share (BPS) Analysis By End-Users
13.20 Absolute $ Opportunity Assessment By End-Users
13.21 Market Attractiveness Analysis By End-Users
Chapter 14 Latin America Contrast Media Injectors Analysis and Forecast
14.1 Introduction
14.2 Latin America Contrast Media Injectors Market Size & Volume Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Contrast Media Injectors Market Size & Volume Forecast By Products
14.6.1 Injector Systems
14.6.1.1 CT Injectors
14.6.1.2 MRI Injectors
14.6.1.3 DSA Injectors
14.6.2 Consumables
14.6.2.1 Syringes
14.6.2.2 Tubes
14.6.2.3 Others
14.6.3 Accessories
14.7 Basis Point Share (BPS) Analysis By Products
14.8 Absolute $ Opportunity Assessment By Products
14.9 Market Attractiveness Analysis By Products
14.10 Latin America Contrast Media Injectors Market Size & Volume Forecast By Injector Types
14.10.1 Single-head Injectors
14.10.2 Dual-head Injectors
14.10.3 Syringeless Injectors
14.11 Basis Point Share (BPS) Analysis By Injector Types
14.12 Absolute $ Opportunity Assessment By Injector Types
14.13 Market Attractiveness Analysis By Injector Types
14.14 Latin America Contrast Media Injectors Market Size & Volume Forecast By Applications
14.14.1 Radiology
14.14.2 Interventional Radiology
14.14.3 Interventional Cardiology
14.15 Basis Point Share (BPS) Analysis By Applications
14.16 Absolute $ Opportunity Assessment By Applications
14.17 Market Attractiveness Analysis By Applications
14.18 Latin America Contrast Media Injectors Market Size & Volume Forecast By End-Users
14.18.1 Hospitals
14.18.2 Diagnostic Centers
14.18.3 Ambulatory Surgery Centers (ASCs)
14.19 Basis Point Share (BPS) Analysis By End-Users
14.20 Absolute $ Opportunity Assessment By End-Users
14.21 Market Attractiveness Analysis By End-Users
Chapter 15 Middle East & Africa (MEA) Contrast Media Injectors Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.2.5 Turkey
15.2.6 Iran
15.2.7 Iraq
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By Products
15.6.1 Injector Systems
15.6.1.1 CT Injectors
15.6.1.2 MRI Injectors
15.6.1.3 DSA Injectors
15.6.2 Consumables
15.6.2.1 Syringes
15.6.2.2 Tubes
15.6.2.3 Others
15.6.3 Accessories
15.7 Basis Point Share (BPS) Analysis By Products
15.8 Absolute $ Opportunity Assessment By Products
15.9 Market Attractiveness Analysis By Products
15.10 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By Injector Types
15.10.1 Single-head Injectors
15.10.2 Dual-head Injectors
15.10.3 Syringeless Injectors
15.11 Basis Point Share (BPS) Analysis By Injector Types
15.12 Absolute $ Opportunity Assessment By Injector Types
15.13 Market Attractiveness Analysis By Injector Types
15.14 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By Applications
15.14.1 Radiology
15.14.2 Interventional Radiology
15.14.3 Interventional Cardiology
15.15 Basis Point Share (BPS) Analysis By Applications
15.16 Absolute $ Opportunity Assessment By Applications
15.17 Market Attractiveness Analysis By Applications
15.18 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By End-Users
15.18.1 Hospitals
15.18.2 Diagnostic Centers
15.18.3 Ambulatory Surgery Centers (ASCs)
15.19 Basis Point Share (BPS) Analysis By End-Users
15.20 Absolute $ Opportunity Assessment By End-Users
15.21 Market Attractiveness Analysis By End-Users
Chapter 16 Competition Landscape
16.1 Contrast Media Injectors Market: Competitive Dashboard
16.2 Global Contrast Media Injectors Market: Market Share Analysis, 2019
16.3 Company Profiles (Details - Overview, Financials, Developments, Strategy)
16.3.1 ulrich GmbH & Co. KG
16.3.2 GENERAL ELECTRIC COMPANY
16.3.3 Bayer HealthCare LLC
16.3.4 Bracco Imaging S.p.A.
16.3.5 Guerbet
16.3.6 SINO MDT
16.3.7 APOLLO RT Co. Ltd.
16.3.8 Shenzhen Anke High-tech Co., Ltd.
16.3.9 Shenzhen Seacrown Electromechanical Co., Ltd
16.3.10 Nemoto Kyorindo Co., Ltd.
16.3.11 Smiths Group plc
16.3.12 AngioDynamics
16.3.13 MEDTRON AG
16.3.14 Company 14
16.3.15 Company 15
Methodology
Related Reports
Some other reports from this category!
Our Clients
